In a report released today, Ryan MacDonald from Needham reiterated a Hold rating on Definitive Healthcare Corp (DH – Research Report). The company’s shares closed yesterday at $8.02.
MacDonald covers the Technology sector, focusing on stocks such as Zeta Global Holdings Corp, Liveperson, and Chegg. According to TipRanks, MacDonald has an average return of 8.8% and a 49.79% success rate on recommended stocks.
Currently, the analyst consensus on Definitive Healthcare Corp is a Moderate Buy with an average price target of $10.50.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $12.46 and a one-year low of $5.53. Currently, Definitive Healthcare Corp has an average volume of 585.5K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Definitive Healthcare Corp (DH) Company Description:
Definitive Healthcare Corp is a leading provider of healthcare commercial intelligence. The company’s solutions provide accurate and comprehensive information on healthcare providers and their activities to help our customers optimize everything from product development to go-to-market planning and sales and marketing execution.
Read More on DH:
- Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal
- Definitive Healthcare management to meet virtually with Needham
- Definitive Healthcare price target raised to $11 from $10 at Barclays
- Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023
- Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
